RxDoctor Payments Data

Young Shin, MD

Psychiatry · Poughkeepsie, NYNPI 1447220884

Payments from drug & device makers

$4,630in general payments, 2019–2025

Across 289 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$600
  • Teva Pharmaceuticals USA, Inc.$446
  • Vanda Pharmaceuticals Inc.$438
  • Sunovion Pharmaceuticals Inc.$415
  • Otsuka America Pharmaceutical, Inc.$332
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$4,624100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,630 in reported general payments places this provider in the 85th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$20,575
Medicare patients
24
Services billed
177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine13$104,596
LybalviOlanzapine/Samidorphan Malate11$19,088
Lurasidone Hcl36$15,125
Aripiprazole89$4,322
Quetiapine Fumarate129$2,866
Clonazepam168$2,438
Duloxetine Hcl75$2,111
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine40$1,995
Prazosin Hcl69$1,456
Alprazolam58$1,245
Ziprasidone Hcl26$1,141
Mirtazapine73$964
Haloperidol27$902
Lamotrigine95$881
Fluvoxamine Maleate14$833

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$446$104,59613 claims
Alkermes, Inc.Lybalvi$283$19,08811 claims
Almatica Pharma LLCSertraline Hcl$25$35350 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Poughkeepsie

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →